Therefore, the aim of the present study was to determine whether recombinant human TRAIL could induce apoptosis in CD138+ and CD138− cells and whether TRAIL in combination with DOX could cause sustained eradication of human MM cells in vitro and in vivo. The gene discussed is SDC1; the disease is Miyoshi myopathy.